Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 192

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 192
---
 date of the Merger Agreement, Enfusion will take all actions necessary or required under the ESPP
to provide that (a) no new offering or purchase period under the Enfusion

120

ESPP will commence after the date of the Merger Agreement, (b) no new participants will be permitted into the Enfusion ESPP after the date of the Merger Agreement, (c) the existing participants in the Enfusion ESPP may not increase their elections with respect to the offering or purchase periods in effect on the date of the Merger Agreement, (d) the exercise date for any offering or purchase period in effect as of the date of the Merger Agreement will be the earlier of the original exercise date for such offering and the Final Exercise Date, (e) each participant’s accumulated contributions under the Enfusion ESPP will be used to purchase shares of Enfusion Common Stock in accordance with the terms of the Enfusion ESPP as of the Final Exercise Date, and (f) the Enfusion ESPP will terminate on the date immediately prior to the date on which the Effective Time occurs. Representations and Warranties The Merger Agreement contains representations and warranties of Enfusion and the Buyer Parties. In the Merger Agreement, Enfusion made customary representations and warranties to the Buyer Parties that are subject, in some cases, to specified exceptions and qualifications contained in the Merger Agreement. These representations and warranties relate to, among other things:

| • |     | due organization, valid existence, good standing and authority and qualification to conduct business with respect 
 to Enfusion and its subsidiaries;                                                                                 |

| • |     | Enfusion’s and Enfusion OpCo’s requisite corporate power and authority to enter into and perform the 
 Merger Agreement and the enforceability of the Merger Agreement;                                     |

| • |     | the necessary approval of the Special Committee and the Enfusion Board; |

| • |     | the requisite vote of Enfusion Stockholders in connection with the Merger Agreement; |

| • |     | the approval of the managing member of Enfusion OpCo in connection with the Merger Agreement; |

| • |     | required consents, approvals and regulatory filings in connection with the Merger Agreement and performance 
 thereof;                                                                                                    |

| • |     | the absence of any conflict or violation of any organizational documents of Enfusion and Enfusion OpCo, certain                                                                                                                                           
 existing contracts of Enfusion and its subsidiaries, applicable law or order to Enfusion or its subsidiaries or the resulting creation